Skip to content
lifestyle.timesla.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
B. Braun Medical Inc.
B. Braun Announces Approval and Commercialization of First Generic Sugammadex Injection in the U.S. Market
July 14, 2026
B. Braun Launches Rocuronium Bromide Injection in a Room-Temperature-Stable Prefilled Syringe
May 23, 2026
B. Braun Announces Significant Reduction of Greenhouse Gas Emissions through Renewable Electricity Purchase Agreements
March 5, 2026
B. Braun Announces Retirement of Chief Executive Officer Rob Albert
February 9, 2026